About FDA

DDI Webinar- “Introduction to FDA’s MedWatch Adverse Reporting Program”- February 9, 2016

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On February 9, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: "Introduction to FDA’s MedWatch Adverse Reporting Program". The featured speaker, Brenda J. Rose Pharm.D., is a Health Professional Program’s Coordinator in FDA’s Office of Health and Constituent Affairs. She gave an overview of the program, how to report adverse events to FDA MedWatch, and where to find clinically relevant information from Medwatch.

This is Part 1 of 2 Webinars with information on Safety Reporting. Part 2 will be held on February 23, 2016.

Presentation Information

Page Last Updated: 04/28/2016
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English